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Safety and Clinical Outcomes of Endovascular Treatment for Extrinsic Pulmonary
Artery Stenosis: A Systematic Review
Mohammed A. Chowdhury, Mujeeb A. Sheikh, George V. Moukarbel
University of Toledo, Toledo, OH
Background: Endovascular stent implantation for extrinsic pulmonary arterial ste-
nosis (PAS) in adults is anecdotal.
Method: We systematically reviewed etiology, clinical characteristics, safety and
outcomes of the published cases of extrinsic PAS treated with endovascular approach.
Result: A total of 113 published cases of extrinsic PAS were reviewed. The most
common etiology of extrinsic PAS was mediastinal mass (31%), primary tumors of
pulmonary artery (27%), ﬁbrosing mediastinitis (18%), pulmonary pseudoaneurysm
(17%), anastomotic stenosis post lung transplantation (7%) and radiation induced
pulmonary stenosis (1%). Mean age at presentation was 52 years  14.75 with a M:F
ratio of 1:1. Dyspnea (41%) was the most common presenting symptom followed by
chest pain (29%), hemoptysis (11%), cough (11%), peripheral edema (7.4%), right
heart failure (6%) and pulmonary hypertension (3%). Right Pulmonary artery was
involved in 40%, bilateral pulmonary artery in 35% and left pulmonary artery in 15% of
cases. 41(36%) cases reported stent implantation with Palmaz, Wall stent and stent
grafts being commonly used stents. In all cases endovascular treatment was associated
with symptom improvement along with reduction in trans-lesional gradient. 6 (15%)
cases reported immediate complications after stent implantation. In 7 (17%) cases in-
stent restenosis was reported at 6 months follow-up. There was no immediate peri-
procedural mortality.
Conclusion: Stent implantation is an effective and safe alternative option for the
treatment of extrinsic PAS.
CRT-204
Same Day Discharge Right and Left Catheterization to Test Vasoreactivity in Pulmonary
Hypertention by Basilar and Radial Access
Luis Enrique Berumen Dominguez, Jose Luis Ojeda-Delgado, Hugo Gutierrez-Leonard,
Luis Manuel Paez-Lizarraga, Miguel Ramirez-Aldaraca
Hospital Militar, Mexico, Mexico
Background: Pulmonary Hypertension is a frequent disease in third level hospitals,
with elevated morbidity and mortality in short time. To choose the medical treatment
is fundamental to do a pulmonary vasoreactivity test.
Objective: To show and classify the results of the vasoreactivity test in the different
groups of pulmonary Hypertension, done by basilar and radial Access.
Material and Method: By consecutive simple we captured cases in which left and
right catheterism is done in patients with pulmonary hypertension, since November
2010 to September 2013. By basilar access we did the right catheterism, oximetries and
pressure are registered, in superior vena cava, Inferior vena cava, Right Ventricle and
Pulmonary Trunk. By radial Access pressures and oximetries are registered in aorta
and Left Ventricle. Cardiac output is determined by Fick Method. The vasoreactivity
was evaluated with adenosine infusion in the pulmonary trunk, in doses of 100 mcg/
kg/min with a maximum of 12 mgs. A positive test is considered when Mean Pul-
monary arterial pressure (mPAP) decrease more than 10 mmHg or a (mPAP) less than
40 mmHg without affection of the cardiac output.
Results: 114 procedures were done, 57% women, mean age 44 years, 74 patients of
the group 1, 26 of the group 2, 8 of the group 3 and 6 of the group 4. Only 12% of the
patients responded to adenosine infusion, 11 patients from the group 1 and 3 patients
from de group 3 (Pulmonary Hypertension classiﬁcation, Dana Point 2008). The
mPAP decreased on average of 17 mmHg, and it was sustained in average 7.2 minutes.
All procedures were done successfully and same day discharge. Complications: 2 pa-
tients referred severe chest pain with the adenosine infusion, but not persistent elec-
trocardiographic abnormalities are founded. 10% of patients presented pain in the
Access site that was controlled with analgesics.
Conclusions: Basilar and radial Access was accepted in 100% percent of the patients,
and all are same day discharged. The were no major complications and the vasoreactivity
test was positive only in 8% of the patients, principally patients of the group 1.Neurovascular Intervention
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Impact of Veins Endovascular Procedures on the Quality of Life in Patients with
Multiple Sclerosis
Marjeta Zorc,1 Miro Denislic,2 Zoran Milosevic,3 Rok Zorec,1 Dean Ravnik,1
Ruda Zorc Pleskovic,1 Ales Pleskovic,3 Oscar Mendiz4
1University of Ljubljana, Medical Faculty, Ljubljana, Slovenia; 2Medical Centre Medicor,
Ljubljana, Slovenia; 3University Clinical Centre Ljubljana, Ljubljana, Slovenia;
4Favaloro foundation, Buenos Aires, Argentina
Background: Chronic cerebrospinal venous insufﬁciency (CCSVI) is a new challenge
of extracranial venous pathway, which provides at present still controversial insight into
the vascular role of multiple sclerosis (MS). The aim of our open-label study was to
evaluate quality of life (QoL) of MS patients after endovascular procedures.
Materials and Methods: MS patients diagnosed by revised McDonald criteria who
fulﬁlled Doppler sonography criteria for CCSVI. To evaluate the efﬁcacy of the
vascular procedures on QoL Multiple Sclerosis Impact Scale (MSIS-29), Fatigue
Severity Scale (FSS), Modiﬁed Fatigue Impact Scale (MFIS) and Overactive bladder
self-administered questionnaire (OAB-V8) were used. MSIS-29, FSS, MFIS and
OAB-V8 were evaluated at baseline, 3, 6, and 12 months after vascular angioplasty.
Results: In our study 72 consecutive MS patients were included. FSS (p<0.001) and
MFIS scores - total score, as well as three subscales scores (physical, psychosocial and
cognitive) signiﬁcantly improved after vascular procedures (p<0.05). The physical
subscale correlated with the degree of pyramidal impairment. The important
improvement of the bladder function using OAB-V8 (p<0.01) and QoL assessed by
MSIS-29 questionnaire (p<0.01) were obtained.
Conclusions: The endovascular procedure demonstrated a beneﬁcial effect on the
quality of life of MS patients. The amelioration of cerebral venous drainage signiﬁ-
cantly reduced the perception of fatigue, increased the mental health and emotional
stability, respectively. Additionally, important improvement of the bladder dysfunction
even in MS patients with the progressive course of disease was achieved. Also, the
sexual function improved. The relationship between CCSVI and hypoperfusion was
demonstrated. The role of better cerebrospinal ﬂuid ﬂow after vascular procedures is
discussed. It seems that the endovascular procedures in MS patients may inﬂuence the
clinical picture of MS patients. Further investigations also in other neurodegenerative
diseases are recommended.
CRT-206
Safety and Efficacy of Carotid Stenting in the Treatment of Carotid Artery Stenosis:
Immediate Results and Long Term Follow-Up in Our Experience
Cinzia Moncalvo,1 Vincenzo Puma,1 Mario Caprile,1 Angelo Laurenza,1
Giuseppe Celano,2 Eugenio Novelli,2 Giuseppe Carosio,1 Paolo Ciofﬁ1
1NCC Città di Alessandria, Alessandria, Italy; 2Clinica San Gaudenzio, Novara, Italy
Background: Carotid artery stenting (CAS) may be an alternative to surgical
endoarterectomy for the treatment of atherosclerotic carotid artery stenosis.
Purpose: to analyze retrospectively the procedures of CAS performed in our Centre
between January 2004 and December 2012.
Methods: This analysis includes 604 procedures performed in 554 patients (382 men;
mean age: 72 years old). Symptomatic patients with carotid artery stenosis > 50% were
the 45%; we treated asymptomatic patients affected by > 70% stenosis. 398 patients
(72%) were considered at high surgical risk: 207 (37%) with severe controlateral ste-
nosis; 136 (24%) with severe or unstable angina, poor left ventricular function, left
main disease or trivascular coronary artery disease, severe cardiac valve disease; 35
patients (6%) presented restenosis after surgical treatment. 28 (5%) patients were
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108 (19%) patients underwent staged CABG one month after CAS. Distal cerebral
protection devices were used in 85% of the procedures. Soft plaques were present in
110 patients (18%). 49 (9%) patients were submitted to CAS for bilateral carotid artery
stenosis.
Results: we obtained a successful immediate angiography result in 99% of the pa-
tients. Major complications occurred in 11 patients (1.9%) and included: death (1 fatal
stroke), major stroke (3), intracerebral hemorrhagic stroke (1), minor stroke (5), acute
instent thrombosis (1 patient treated with thromboendoarterectomy and stent
removal). Puncture site hematoma occurred in 4 patients treated with vascular surgical
repair, one patient died for hemorrhagic shock.
Follow-up: we have a complete follow up in 95% of the patients. Instent restenosis
occurred in 6 patients (1%) and was successfully treated with a new CAS. 50 patients
died (22 for cardiovascular causes), but no one died for causes directly related to CAS.
Conclusions: in our experience CAS is a safety procedure with low complications also
in high risk patients; the long term efﬁcacy of CAS is very good with low rate of
restenosis.
Peripheral Vascular Intervention
CRT-207
Role of Nitinol Stent Fractures in the Development of In-Stent Restenosis in the
Superficial Femoral Artery
Anna Kurayev, Susanna Zavlunova, Anvar Babaev
NYU Langone School of Medicine, New York, NY
Background: In-stent restenosis (ISR) in the superﬁcial femoral artery (SFA) remains
to be an Achilles heel of endovascular treatment of obstructive PAD. Stent fracture
(SF) was identiﬁed as one of possible causes of ISR, but data on the role of SF in
development of ISR remains controversial.
Methods: We studied 97 consecutive patients (105 limbs) with angiographically
conﬁrmed obstructive nitinol self-expandable stent ISR in the SFA. Mean age of the
group was 73.318.28 years, 45% females, 31% smokers, 65% Diabetes. We excluded
patients with Viabahn stents. Stents were evaluated by ﬂuoroscopy/ CINE using at least
2 orthgonal views for SF presence. We analyzed SF rates, severity and angiographic
relationship to restenosis, number of stents, stented length, stent diameter and type, run
off score, smoking, age, sex, and presence of co-morbidities were analyzed as well.
Results:Mean time from stent implantation to presentation with ISR was 15.515.3
months. Out of 105 limbs with ISR, SF was present in 31 (30%) limbs and among
those only 3 (10%) limbs had SF angiographically associated with ISR. SF occurred
more frequently in males (p<0.036). Mean stented length was numerically but not
statistically longer in patients with SF than in those without, 218.1101 versus
194.8103.2 (p¼0.297), respectively. There were no differences in other procedural
and demographic characteristics between groups with and without SF.
Conclusions: Stent fractures in SFA play a modest role in the development of ISR. In
our study, the association was seen in only 10% limbs (3 out of 31 limbs) with SF,
which corresponds to 2.9% of total 105 limbs with ISR. Majority of the patients with
ISR did not have SF. Stent fracture occurred more frequently in males.CRT-208
Comparison of Peripheral Arterial Chronic Total Occlusion Crossing Strategies in the
XLPAD Registry
Omar Hadidi,1 Atif Mohammad,1 Karan Sarode,1 Gene Pershwitz,2 Rahul Thomas,1
Ariel Vinas,1 Mazen Abu-fadel,3 Jose Exaire,4 Beau Hawkins,5 Swagata Das,2
Robert Dieter,6 Andrew Klein,7 Osvaldo Gigliotti,8 Thomas Tsai,9 Mir Ishti Ali,10
Scott Kinlay,11 Michael Luna,1 Nicolas Shammas,12 Anand Prasad,13 Tayo Addo,1
Emmanouil S. Brilakis,1 Subhash Banerjee1
1University of Texas Southwestern Medical Center/VA North Texas Health Care System,
Dallas, TX; 2VA North Texas Health Care System, Dallas, TX; 3University of Oklahoma
Health Sciences Center, Oklahoma City, OK; 4University of Oklahoma Health sciences
Center, Oklahoma, OK; 5University of Oklahoma Health Sciences Center/Oklahoma VA
Medical Center, Oklahoma, OK; 6Hines VA Medical Center, Chicago, IL; 7St.Louis VA
Medical Center, St. Louis, MO; 8Seton Heart Institute, Austin, TX; 9VA Eastern Colorado
Health Care System, Denver, CO; 10Ball Memorial Hospital, Muncie, IN; 11VA Boston
Health Care System, Boston, MA; 12Midwest Cardiovascular Research Foundation,
Davenport, IA; 13University of Texas Health Sciences Center at San Antonio,
San Antonio, TX
Background: Successful treatment of superﬁcial femoral artery (SFA) and below-the
knee (BTK) chronic total occlusions (CTO) involves selection of an optimal crossing
strategy (‘wire-catheter’ vs. dedicated CTO crossing device).
Methods: We analyzed data from the multi-center XLPAD registry between July
2005 and September 2013 to compare primary CTO crossing strategies.
Results: A total of 343 SFA and BTK CTO interventions on 246 patients with
symptomatic peripheral arterial disease were performed; 63.0% lesions were attempted
with a primary ‘wire-catheter’ and 37.0% with a primary crossing device. In the pri-
mary ‘wire-catheter’ group 64.4% lesions were successfully crossed, 34.3% required a
provisional crossing device and 1.4% were failures. Provisional use of a crossing device
following a failed primary ‘wire-catheter’ attempt was successful in 95.9% cases. In the
primary crossing device arm, 95.3% of lesions were successfully crossed. Figure 1
depicts comparative success rates with the primary ‘wire-catheter’ and crossing device
strategies. Lesion lengths in the primary ‘wire catheter’ and crossing device arms were
138.984.9 and 135.779.6 mm (p¼0.75) with stent lengths of 166.9150.6 and
163.2153.1 mm (p¼0.84), respectively.
Conclusion: In contemporary practice, most operators select a primary ‘wire-catheter’
strategy to cross infra-inguinal peripheral arterial CTO, which is associated with lower
success compared to a primary crossing device strategy.
